In the course of screening for new high molecular weight peptidoglycan synthesis inhibitors, izupeptins A and B, antibiotics active against Gram-positive bacteria including methicillin-resistant Staphylococci and Clostridium were discovered. The antibiotics were found to be new members of the glycopeptide antibiotic family, namely of the vancomycin type, based on chemical and spectroscopic data. The molecular weight of izupeptin A was determined to be 1,475 by SI (secondary ion)-MS (integer molecular weight, 1,473), and it contains two chlorine atoms.
In our earlier screening for specific inhibitors of cell wall peptidoglycan synthesis, which was based on lack of activity against Mycoplasma and selective inhibition of incorporation of [3H]diaminopimeric acid (DAP) into acid-insoluble macromolecular fraction of growing Bacillus sp. ATCC 21206 (DAP-) cells,1,2) we found, among others, 15 strains producing high molecular weight inhibitors as estimated from the percentage of passage through an Amicon UM-2 membrane. After partial purification and comparison by HPLC of the active components of these 15 strains with known antibiotics mainly of the glycopeptide family, we found one strain (AM-5289) producing a new member of this group of antibiotics. Spectral and chemical of the purified substances, named izupeptins A and B, revealed a close relationship to the vancomycin-type.
The present paper deals with taxonomy of the izupeptin-producing strain, production, isolation and chemical and biological characterization of the antibiotics. In their field desorption (FD) or electron impact (EI) mass spectra, the molecular ion peak could not be observed because of their high molecular weights and/or high polarities, while the secondary ionization mass spectrometry (SI-MS) gave the (M+H)+ ion peak of izupeptin A at m/z 1,474. That of B, however, could not be obtained, as the component contained some impurity. In the SI-MS spectrum of A, two characteristic fragment ion peaks, m/z 1,332 and 1,171, reflecting the structural feature were observed. It suggests that A contains two carbohydrate components. The ion peak pattern of the (M=H)+ region clearly indicated that the antibiotics contain two chlorine atoms.7) THE JOURNAL OF ANTIBIOTICS DEC. 1986 Biological Properties
The antimicrobial spectra of izupeptins A and B were determined by a conventional agar dilution method using Sensitivity Test Agar (Nissui) for aerobic bacteria and GAM Agar (Nissui) for anaerobic bacteria. The plates were incubated at 37°C for 20 hours. The antimicrobial activities of izupeptins A and B were compared with those of the known glycopeptide antibiotics vancomycin and teicoplanin.
As shown in Table 2 , izupeptins A and B showed potent inhibitory activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus strains and some anaerobes, but slightly weaker than vancomycin and teicoplanin. Izupeptins A and B showed no adverse effect when administered intraperitoneally to mice at 200 mg/kg. 
Discussion
In the course of our screening for new high molecular weight peptidoglycan synthesis inhibitors, we discovered new members of the glycopeptide family, named izupeptins A and B. The SI-MS spectrum of component A revealed a molecular weight of 1,475 (integer molecular weight, 1,473), suggests that the antibiotics are related to vancomycin.
Recently further vancomycinrelated antibiotics, demethylvancomycin8) and M43 series,'' have been reported. However, izupeptin A can be differentiated from these antibiotics in molecular weight. The difference in structure is under investigation.
